Technivie
Active Ingredient(s): Ombitasavir + Paritaprevir + RitonavirFDA Approved: * July 24, 2015
Pharm Company: * ABBVIE INC
Category: Hepatitis
Ombitasvir/paritaprevir/ritonavir, sold under the brand name Technivie among others, is a medication used to treat hepatitis C.[1] It is a fixed-dose combination of ombitasvir, paritaprevir, and ritonavir.[1] Specifically it is used together with dasabuvir or ribavirin for cases caused by hepatitis C virus genotype 1 or 4.[1][2] Cure rates are around 95%.[2] It is taken by mouth.[1] It is generally... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.